Salivary Lysozymes, Anti-inflammatory Cardiac Medications, and Cardiovascular Mortality.
- DOI
- 10.1177/23800844261479727
- Published
- 2026 Sep 11
- Container
- JDR clinical and translational research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/23800844261479727,
title = {Salivary Lysozymes, Anti-inflammatory Cardiac Medications, and Cardiovascular Mortality.},
author = {Janket SJ and Tamimi F and Baird AE and Surakka M and Di Paolo C and Lee C and Van Dyke TE and Meurman JH},
year = {2026},
journal = {JDR clinical and translational research},
doi = {10.1177/23800844261479727},
url = {https://doi.org/10.1177/23800844261479727}
}RIS
TY - JOUR TI - Salivary Lysozymes, Anti-inflammatory Cardiac Medications, and Cardiovascular Mortality. AU - Janket SJ AU - Tamimi F AU - Baird AE AU - Surakka M AU - Di Paolo C AU - Lee C AU - Van Dyke TE AU - Meurman JH PY - 2026 JO - JDR clinical and translational research DO - 10.1177/23800844261479727 UR - https://doi.org/10.1177/23800844261479727 ER -
APA
SJ, J., F, T., AE, B., M, S., C, D. P., C, L., TE, V. D., & JH, M. (2026). Salivary Lysozymes, Anti-inflammatory Cardiac Medications, and Cardiovascular Mortality.. JDR clinical and translational research. https://doi.org/10.1177/23800844261479727
Source records
- pubmed · retrieved 2026-09-25T20:59:56.899Z